文献速递胃肠外科

腹腔镜与机器人胃切除术结局比较:美国国家癌症数据库研究

Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study.
PubMed 文献 · Surg Endosc · 2023-07-11

该研究基于美国国家癌症数据库,比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)治疗胃腺癌的肿瘤学结局。共纳入1301例RG和4892例LG患者。RG组R0切除率更高(94.5% vs 91.9%,p=0.001)、中转开腹率更低(7.1% vs 16%,p<0.001),5年生存率更高(56% vs 52%,p=0.03),30天再入院、30天及90天死亡率无差异。

要点

  • RG组R0切除率94.5%,高于LG组的91.9%(p=0.001)。
  • RG组中转开腹率7.1%,低于LG组的16%(p<0.001)。
  • RG组5年生存率56%,LG组52%(p=0.03)。

核心结论

  • 机器人与腹腔镜胃切除术均为可接受的术式,但机器人组中转开腹率更低、R0切除率更高,且显示生存获益。

研究设计与样本

  • 基于美国国家癌症数据库的回顾性队列研究,纳入1301例机器人胃切除术和4892例腹腔镜胃切除术患者,排除开放手术患者。

主要发现

  • 机器人组与腹腔镜组中位年龄分别为65岁(范围20-90)和66岁(范围18-90),p=0.02。
  • 腹腔镜组平均阳性淋巴结数2.2±4.4枚,机器人组1.9±3.8枚,p=0.01。
  • 机器人组R0切除率94.5%,腹腔镜组91.9%,p=0.001。
  • 机器人组中转开腹率7.1%,腹腔镜组16%,p<0.001。
  • 两组中位住院时间均为8天(6-11天),30天再入院(p=0.65)、30天死亡率(p=0.85)和90天死亡率(p=0.34)无差异。

临床怎么用

  • 机器人胃切除术可作为胃腺癌根治性手术的可接受选择,尤其在意愿降低中转开腹率和提高R0切除率时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer is associated with significant mortality worldwide. Radical gastrectomy with lymphadenectomy is considered the only curative option. Traditionally, these operations are associated with significant morbidity. Laparoscopic gastrectomy (LG) and more recently robotic gastrectomy (RG) techniques have been developed to potentially decrease the perioperative morbidity. We sought to compare oncologic outcomes with laparoscopic and robotic techniques for gastrectomy. METHODS: Utilizing the National Cancer Database we identified patients who underwent gastrectomy for adenocarcinoma. Patients were stratified by open, robotic or laparoscopic surgical technique. Open gastrectomy patients were excluded. RESULTS: We identified 1,301 patients who underwent RG and 4,892 LG with median ages of 65 (20-90) and 66 (18-90) respectively, p = 0.02. The mean number of positive lymph nodes were higher in the LG 2.2 ± 4.4 vs RG 1.9 ± 3.8, p = 0.01. The R0 resections were higher in the RG at 94.5% vs 91.9% in LG, p = 0.001. Conversions to open were 7.1% in the RG and 16% in the LG group, p < 0.001. The median length of hospitalization was 8 (6-11) in both groups. There was no difference in the 30-day readmission (p = 0.65), 30-day mortality (p = 0.85) and 90-day mortality (p = 0.34) between groups. The median and overall 5-year survival was 71.3 mo and 56% in the RG and 66.1 mo and 52% in the LG, p = 0.03. Multivariate analysis revealed that age, Charlson-Deyo comorbidity scores, location of gastric cancer, histology grade, pathologic T-stage, pathologic N-stage, surgical margins, and facility volume were all predictors of survival. CONCLUSIONS: Robotic and laparoscopic techniques are both acceptable approaches to gastrectomy. However, conversions to open are higher and R0 resections rates are lower in the laparoscopic group. Additionally, a survival benefit is demonstrated in those undergoing robotic gastrectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Takahashi C, Glasser J, Schuster C, et al. Comparative outcomes of laparoscopic and robotic approaches to gastrectomy: a National Cancer Database study. Surg Endosc. 2023. PMID: 37433916. doi:10.1007/s00464-023-10204-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。